Evidence map›Paper›PMID 33917901›Full record

ArticleAntioxidants (Basel, Switzerland)2021

Accumulation of Carbonyl Proteins in the Brain of Mouse Model for Methylglyoxal Detoxification Deficits.

Shin Koike, Kazuya Toriumi, Sakura Kasahara, Yosuke Kibune, Yo-Ichi Ishida, Takashi Dan, Toshio Miyata, Makoto Arai, Yuki Ogasawara

Open access · goldAbstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Shin KoikeDepartment of Analytical Biochemistry, Meiji Pharmaceutical University, Tokyo 204-8588, Japan.
Kazuya ToriumiSchizophrenia Research Project, Department of Psychiatry and Behavioral Sciences, Tokyo Metropolitan Institute of Medical Science, Tokyo 156-8506, Japan.
Sakura KasaharaDepartment of Analytical Biochemistry, Meiji Pharmaceutical University, Tokyo 204-8588, Japan.
Yosuke KibuneDepartment of Analytical Biochemistry, Meiji Pharmaceutical University, Tokyo 204-8588, Japan.
Yo-Ichi IshidaDepartment of Microbial Science and Host Defense, Meiji Pharmaceutical University, Tokyo 204-8588, Japan.
Takashi DanDivision of Molecular Medicine and Therapy, Tohoku University Graduate School of Medicine, Sendai 980-8575, Japan.
Toshio MiyataDivision of Molecular Medicine and Therapy, Tohoku University Graduate School of Medicine, Sendai 980-8575, Japan.
Makoto AraiSchizophrenia Research Project, Department of Psychiatry and Behavioral Sciences, Tokyo Metropolitan Institute of Medical Science, Tokyo 156-8506, Japan.ORCID 0000-0003-3400-9815
Yuki OgasawaraDepartment of Analytical Biochemistry, Meiji Pharmaceutical University, Tokyo 204-8588, Japan.
Meiji Pharmaceutical University · JPTohoku University · JPTokyo Metropolitan Matsuzawa Hospital · JP

Funding

Japan Society for the Promotion of Science 16H05380Japan Society for the Promotion of Science 17H05930Japan Society for the Promotion of Science 18K06977Japan Society for the Promotion of Science 19H04887Japan Society for the Promotion of Science 19K07208Japan Society for the Promotion of Science 19K16425Japan Society for the Promotion of Science 20H03608
6 · The paper itself

Abstract

Recent studies have shown that carbonyl stress is a causative factor of schizophrenia, categorized as carbonyl stress-related schizophrenia (CS-SCZ). However, the correlation between carbonyl stress and the pathogenesis of this disease is not well established. In this study, glyoxalase 1(Glo1)-knockout and vitamin B6-deficient mice (KO/VB6 (-) mice), which are susceptible to methylglyoxal (MGO)-induced oxidative damages, were used as a CS-SCZ model to analyze MGO-modified protein and the carbonyl stress status in the brain. A comparison between Wild/VB6(+) mice and KO/VB6(-) mice for accumulated carbonyl proteins levels, with several advanced glycation end products (AGEs) in the brain, revealed that carbonyl protein levels with the Nδ-(5-hydro-5-methyl-4-imidazolon-2-yl) ornithine (MG-H1) moiety were significantly increased in the hippocampus, prefrontal cortex, striatum, cerebral cortex, and brainstem regions of the brain in KO/VB6(-) mice. Moreover, two-dimensional electrophoresis and Liquid chromatography-tandem mass spectrometry analysis showed MG-H1-modified arginine residues in mitochondrial creatine kinase, beta-adrenergic receptor kinase 1, and T-complex protein in the hippocampus region of KO/VB6(-) mice, but not in Wild/VB6(+) mice. In particular, MG-H1 modification of mitochondrial creatine kinase was quite notable. These results suggest that further studies focusing on MG-H1-modified and accumulated proteins in the hippocampus may reveal the onset mechanism of CS-SCZ induced by MGO-induced oxidative damages.

Indexed as

carbonyl stressmethylglyoxal-induced oxidative damagesmitochondrial creatine kinasepyridoxaminescavengerschizophrenia

Identifiers

PMID33917901
PMCPMC8068291
OpenAlexW3154521710

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.